NCT03106519View on ClinicalTrials.gov

Liposome Bupivacaine for WRIST Blocks

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

June 28, 2017

Study Completion Date

October 31, 2017

Conditions
Dupuytren's Contracture of the Hand (Viking's Disease)
Interventions
DRUG

Liposome bupivacaine + bupivacaine

Trial Locations (1)

B-3600

Ziekenhuis Oost-Limburg, Genk

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

Catherine Vandepitte, M.D.

OTHER